$HIMS: Shorts are in trouble. - 30%+ of the float sold short - new $NVO partnership - new global acquisitions + recovering macro climate. And regulatory de-risking is now in place. They're expanding like crazy: - EG. Healing: BPC-157 and Thymosin beta-4 - Hair & Skin:

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin